opioids
| 3 min read
Vertex Pharmaceuticals’ drug, Journavx, blocks a sodium channel outside of the brain. Experts hope that this non-addictive pain drug may be the first of many.
| 5 min read
Researchers studied an antidepressant that may help treat neuropathic pain.
| 4 min read
A promising relationship between acetylcholine signaling and pain relief in mice could point the way to a non-opioid therapeutic.
| 8 min read
New research aims to make antibody drug delivery as precise and efficient as the antibodies themselves.
Available on Demand
Researchers harness pharmacogenomics to understand why individual patients react differently to opioids for pain relief.
| 4 min read
Researchers precisely engineered an antibody to better treat respiratory depression due to overdose from increasingly prevalent synthetic opioids.
Page 1 of 1 - 6 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
